Coste del desperdicio de tratamiento en niños tratados con hormona de crecimiento humana recombinante administrada a través de diferentes dispositivos en España

This study compares the annual wastage costs of r-hGH treatment administered with Easypod® versus other approved devices in Spain.

Authors: María Dolores Edo, Olga Durán Morán, Carla Gari Peris; Olga Ojeda Rife, Jose Luis Poveda

Year: 2023

Congress: XLII Jornadas de Economía de la Salud

Outside URL

Subscribe to Outcomes´10

Name *

E-mail *

Todos los campos marcados con un * son obligatorios

Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. Data will be retained for the time necessary to fulfill its purpose and derived responsibilities by current regulations and the deadlines in the applicable regulations on archives and documentation. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy

I have read and accepted the privacy policy